Bandello F - Search Results

1

Different Outcomes of Anti-VEGF Treatment for Neovascular AMD according to Neovascular Sutypes and Baseline Features: 2-Year Real-Life Clinical Outcomes.

Arrigo A, Saladino A, Aragona E, Mercuri S, Introini U, Bandello F, Parodi MB. Arrigo A, et al. Among authors: bandello f. Biomed Res Int. 2021 May 24;2021:5516981. doi: 10.1155/2021/5516981. eCollection 2021. Biomed Res Int. 2021. PMID: 34124243 Free PMC article. Clinical Trial.

2

Early neovascular bridging after photodynamic therapy of myopic choroidal neovascularization.

Lanzetta P, Parodi MB, Ambesi-Impiombato M, Ravalico G, Bandello F. Lanzetta P, et al. Among authors: bandello f. Graefes Arch Clin Exp Ophthalmol. 2004 Oct;242(10):840-4. doi: 10.1007/s00417-004-0904-0. Epub 2004 Jun 22. Graefes Arch Clin Exp Ophthalmol. 2004. PMID: 15221306

3

Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization associated with multifocal choroiditis.

Parodi MB, Di Crecchio L, Lanzetta P, Polito A, Bandello F, Ravalico G. Parodi MB, et al. Among authors: bandello f. Am J Ophthalmol. 2004 Aug;138(2):263-9. doi: 10.1016/j.ajo.2004.03.029. Am J Ophthalmol. 2004. PMID: 15289136

4

Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy.

Menchini U, Virgili G, Introini U, Bandello F, Ambesi-Impiombato M, Pece A, Parodi MB, Giacomelli G, Capobianco B, Varano M, Brancato R. Menchini U, et al. Among authors: bandello f. Retina. 2004 Oct;24(5):763-71. doi: 10.1097/00006982-200410000-00013. Retina. 2004. PMID: 15492632

5

Branch retinal vein occlusion: classification and treatment.

Parodi MB, Bandello F. Parodi MB, et al. Among authors: bandello f. Ophthalmologica. 2009;223(5):298-305. doi: 10.1159/000213640. Epub 2009 Apr 16. Ophthalmologica. 2009. PMID: 19372724 Review.

6

Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia.

Parodi MB, Iacono P, Papayannis A, Sheth S, Bandello F. Parodi MB, et al. Among authors: bandello f. Arch Ophthalmol. 2010 Apr;128(4):437-42. doi: 10.1001/archophthalmol.2009.408. Epub 2010 Feb 8. Arch Ophthalmol. 2010. PMID: 20142520 Clinical Trial.

7

Intravitreal bevacizumab for subfoveal choroidal neovascularization associated with pattern dystrophy.

Parodi MB, Iacono P, Cascavilla M, Zucchiatti I, Kontadakis DS, Bandello F. Parodi MB, et al. Among authors: bandello f. Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4358-61. doi: 10.1167/iovs.10-5237. Epub 2010 Apr 7. Invest Ophthalmol Vis Sci. 2010. PMID: 20375343 Clinical Trial.

8

Juxtafoveal choroidal neovascularization secondary to persistent placoid maculopathy treated with intravitreal bevacizumab.

Parodi MB, Iacono P, Bandello F. Parodi MB, et al. Among authors: bandello f. Ocul Immunol Inflamm. 2010 Oct;18(5):399-401. doi: 10.3109/09273948.2010.483316. Ocul Immunol Inflamm. 2010. PMID: 20666681

9

Bevacizumab vs photodynamic therapy for choroidal neovascularization in multifocal choroiditis.

Parodi MB, Iacono P, Kontadakis DS, Zucchiatti I, Cascavilla ML, Bandello F. Parodi MB, et al. Among authors: bandello f. Arch Ophthalmol. 2010 Sep;128(9):1100-3. doi: 10.1001/archophthalmol.2010.205. Arch Ophthalmol. 2010. PMID: 20837791 Clinical Trial.

10

Intravitreal bevacizumab in a patient with a macular star in malignant hypertension.

Zucchiatti I, Iacono P, Battaglia Parodi M, Cascavilla ML, Kontadakis DS, Bandello F. Zucchiatti I, et al. Among authors: bandello f. Eur J Ophthalmol. 2011 May-Jun;21(3):336-9. doi: 10.5301/EJO.2010.5819. Eur J Ophthalmol. 2011. PMID: 20954147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,108 results

Search Page

Filters